Subscribe for stories that matter!
The recent shareholder decision regarding the merger between Strongbridge Biopharma and Xeris Pharmaceuticals was a nearly unanimous yes. John George covered the implications of that…
Before we send you to this site, please subscribe to our daily newsletter.